308 filings
8-K
AMGN
AMGEN Inc.
6 Feb 24
Amgen Reports Fourth Quarter and Full Year 2023 Financial Results
4:20pm
8-K
AMGN
AMGEN Inc.
14 Dec 23
Amgen Announces Executive Appointments to Accelerate Innovation
9:16am
8-K
AMGN
AMGEN Inc.
31 Oct 23
Amgen Reports Third Quarter Financial Results
7:15am
8-K
AMGN
AMGEN Inc.
6 Oct 23
Amgen Completes Acquisition of Horizon Therapeutics PLC
4:01pm
8-K
AMGN
AMGEN Inc.
5 Oct 23
Other Events
7:43am
8-K
jwv a7sf4663i
12 Sep 23
Other Events
7:30am
8-K
qhk9vpdn1syyrx gsnkc
5 Sep 23
Other Events
9:12am
8-K
6z3nqb21
1 Sep 23
Regulation FD Disclosure
9:25am
8-K
96pi7lj j156q3f
3 Aug 23
Departure of Directors or Certain Officers
5:48pm
8-K
aoci0q rp8
3 Aug 23
Amgen Reports Second Quarter Financial Results
4:12pm
8-K
qb47at ftlujfyh
5 Jun 23
Other Events
8:00am
8-K
rml0jw1sfd69lwux sgl
22 May 23
Submission of Matters to a Vote of Security Holders
5:23pm
8-K
00vtqjc26 ogkyl1m
18 May 23
Other Events
8:29am
8-K
ph74s
16 May 23
Regulation FD Disclosure
5:28pm
8-K
1xk0jpy8kb1fktwhq8t
27 Apr 23
Amgen Reports First Quarter Financial Results
4:11pm
8-K
ngm0kih
9 Mar 23
Entry into a Material Definitive Agreement
4:24pm
8-K
rw4r14aey9936
2 Mar 23
Entry into a Material Definitive Agreement
4:28pm
8-K
cizwzv
16 Feb 23
Entry into a Material Definitive Agreement
8:30am
8-K
vptqpf4h9n8js0qp9xd
31 Jan 23
Amgen Reports Fourth Quarter and Full Year 2022 Financial Results
4:15pm
8-K
6jthgkcd0yfxbl30wh
22 Dec 22
Entry into a Material Definitive Agreement
4:43pm